Mitigating factors reduced the penalty.
The healthcare Evolution continues.
The health products company has an option to go to full ownership.
Despite valuing Volpara at a 'mere' US$193m, the Korean bid is competitive.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details